Investigators found that some patients with high-risk nonmetastatic hormone-sensitive prostate cancer were understaged by ...

Investigators assess the impact of increasing persistent PSA levels on prostate cancer–specific mortality and all-cause ...

So as way of background, EZH2 is an epigenetic enzyme that's overexpressed in castrate-resistant prostate cancer, and it's ...

Background: A 59-year-old man on exogenous androgen therapypresented with a clinically palpable prostate nodule confined ... 1D), in addition to borderline enlargement of left external iliac ...

Ageing comes with its fair share of body changes, and for a lot of men, prostate enlargement is one of them. If you’re over 50, the chances of dealing with an enlarged prostate go up ...

The tumor exhibited diffuse invasive growth, extensively infiltrating the left and right lobes, middle and posterior lobes, constituting approximately 80% of the tissue. Local invasion of the urethral ...

Prostate enlargement, a condition affecting only men, becomes more common with age, typically starting after the age of 50-55. Approximately 30-40 million men worldwide experience prostate ...

In mCRPC patients, Talzenna + Xtandi cut death risk by 20%, extending median OS to 45.8 months vs ... with metastatic castration-resistant prostate cancer (mCRPC), with or without homologous ...

Lucknow: The urology department at Ram Manohar Lohia Institute of Medical Sciences (RMLIMS) has for the first time successfully treated two patients with prostate enlargement using the innovative ...

Unilateral amygdala enlargement (AE) is associated with mesial temporal lobe epilepsy (mTLE). In a relatively large sample of patients with mTLE and AE, we aimed to evaluate functional integration of ...